Pirfenidone CAS 53179-13-8 Pirfenidone
Pirfenidone ; 53179-13-8 .Alisa: S-7701;5-methyl-1-phenyl-2-pyridone;5-methyl-1-phenyl-pyridin-2-one;5-methyl-1-phenylpyridin-2-one;Pirfenidone,>=Chemicalbook99%;Pirfenidone(S-7701,AMR-69);2(1H)-Pyridinone,5-Methyl-1-phenyl-;Pirfenidone(5-Methyl-1-Phenyl-2(1H)-Pyridinone)
Product Name:Pirfenidone
CAS: 302776-68-7
Appearance:White powder
Assay:99.0%min
Plenty in stock
MF:C12H11NO
Structure:
Usage:Pirfenidone (PFD) is a new pyridone compound with broad-spectrum anti-fibrotic effect, which can prevent and reverse the formation of fibrosis and scarring; it was launched by Shionogi, Japan in 2008 and has been obtained. Approved by the U.S. Food and Drug Administration, it is the first drug that has demonstrated a certain effect on idiopathic pulmonary fibrosis (IPF) through repeated, randomized, placebo-controlled Phase III clinical trials; Fibrosis, liver fibrosis and other fibrotic diseases also have good curative effect; at the same time, kidney disease (focal segmental glomerulosclerosis), hypertrophic cardiomyopathy, adult type I multiple neurofibroma, adolescent It is widely used in phase II clinical studies of type I multiple neurofibromas and plexiform neurofibromas, diabetes with kidney disease, and uterine leiomyoma.
Pirfenidone Specification:
1.Appearance: white crystalline powder
2.Meltng Point:102-109℃
3.Loss on Drying:≤ 0.5%
4.Assay:≥ 99.0%
Package:25kg/drum
delivery days:3-5 day
Pirfenidone ; 53179-13-8 .Alisa: S-7701;5-methyl-1-phenyl-2-pyridone;5-methyl-1-phenyl-pyridin-2-one;5-methyl-1-phenylpyridin-2-one;Pirfenidone,>=Chemicalbook99%;Pirfenidone(S-7701,AMR-69);2(1H)-Pyridinone,5-Methyl-1-phenyl-;Pirfenidone(5-Methyl-1-Phenyl-2(1H)-Pyridinone)
Product Name:Pirfenidone
CAS: 302776-68-7
Appearance:White powder
Assay:99.0%min
Plenty in stock
MF:C12H11NO
Structure:
Usage:Pirfenidone (PFD) is a new pyridone compound with broad-spectrum anti-fibrotic effect, which can prevent and reverse the formation of fibrosis and scarring; it was launched by Shionogi, Japan in 2008 and has been obtained. Approved by the U.S. Food and Drug Administration, it is the first drug that has demonstrated a certain effect on idiopathic pulmonary fibrosis (IPF) through repeated, randomized, placebo-controlled Phase III clinical trials; Fibrosis, liver fibrosis and other fibrotic diseases also have good curative effect; at the same time, kidney disease (focal segmental glomerulosclerosis), hypertrophic cardiomyopathy, adult type I multiple neurofibroma, adolescent It is widely used in phase II clinical studies of type I multiple neurofibromas and plexiform neurofibromas, diabetes with kidney disease, and uterine leiomyoma.
Pirfenidone Specification:
1.Appearance: white crystalline powder
2.Meltng Point:102-109℃
3.Loss on Drying:≤ 0.5%
4.Assay:≥ 99.0%
Package:25kg/drum
delivery days:3-5 day
Company Information
CAS NO:30123-17-2
CAS NO:7048-04-6
CAS NO:305-84-0
CAS NO:77-86-1
CAS NO:53179-13-8
CAS NO:6038-19-3
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View